PROCEPT BioRobotics (NASDAQ:PRCT) stock is trading on Monday after the company released better-than-expected third-quarter earnings. The company reported EPS loss of $(0.40), down from $(0.51) a year ...
“We are pleased to report another successful quarter with annual revenue growth of 61%. This outstanding performance across all segments of the business reflects continued focus on penetrating BPH ...
Forbes contributors publish independent expert analyses and insights. I write about biodiversity and the hidden quirks of the natural world. Over 390 million years ago, the ancestors of modern land ...
PROCEPT BioRobotics Corporation (NASDAQ:PRCT) ranks among the top robotics to buy according to analysts. On August 7, Wells Fargo maintained its Overweight rating on PROCEPT BioRobotics Corporation ...
SAN JOSE, Calif., Oct. 28, 2024 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics Corporation (PRCT) (the “Company”), a surgical robotics company focused on advancing patient care by developing transformative ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results